Cargando…

The Plasma Level of Interleukin-1β Can Be a Biomarker of Angiopathy in Systemic Chronic Active Epstein–Barr Virus Infection

Systemic chronic active Epstein–Barr virus infection (sCAEBV) is an EBV-positive T- or NK-cell neoplasm revealing persistent systemic inflammation. Twenty-five percent of sCAEBV patients accompany angiopathy. It is crucial to clarify the mechanisms of angiopathy development in sCAEBV because angiopa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ohashi, Ayaka, Uemura, Yu, Yoshimori, Mayumi, Wada, Naomi, Imadome, Ken-Ichi, Yudo, Kazuo, Koyama, Takatoshi, Shimizu, Norio, Nishio, Miwako, Arai, Ayako
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9019545/ https://www.ncbi.nlm.nih.gov/pubmed/35464987 http://dx.doi.org/10.3389/fmicb.2022.874998

Ejemplares similares

Interferon-γ Produced by EBV-Positive Neoplastic NK-Cells Induces Differentiation into Macrophages and Procoagulant Activity of Monocytes, Which Leads to HLH
por: Yoshimori, Mayumi, et al.
Publicado: (2021)

STAT3 is constitutively activated in chronic active Epstein-Barr virus infection and can be a therapeutic target
por: Onozawa, Erika, et al.
Publicado: (2018)

CD137 Expression Is Induced by Epstein-Barr Virus Infection through LMP1 in T or NK Cells and Mediates Survival Promoting Signals
por: Yoshimori, Mayumi, et al.
Publicado: (2014)

P-glycoprotein is expressed and causes resistance to chemotherapy in EBV-positive T-cell lymphoproliferative diseases
por: Yoshimori, Mayumi, et al.
Publicado: (2015)

Updated guidelines for chronic active Epstein–Barr virus disease
por: Kawada, Jun-ichi, et al.
Publicado: (2023)

EBV induces persistent NF-κB activation and contributes to survival of EBV-positive neoplastic T- or NK-cells
por: Takada, Honami, et al.
Publicado: (2017)

Correction: EBV induces persistent NF-κB activation and contributes to survival of EBV-positive neoplastic T- or NK-cells
por: Takada, Honami, et al.
Publicado: (2017)

Humanized Mouse Models of Epstein-Barr Virus Infection and Associated Diseases
por: Fujiwara, Shigeyoshi, et al.
Publicado: (2013)

Epstein-Barr Virus Induces Erosive Arthritis in Humanized Mice
por: Kuwana, Yoshikazu, et al.
Publicado: (2011)

Development of Extranodal NK/T-cell Lymphoma Nasal Type in Cerebrum Following Epstein-Barr Virus-positive Uveitis
por: Imai, Ayano, et al.
Publicado: (2017)

Increased Granulopoiesis in the Bone Marrow following Epstein-Barr Virus Infection
por: Katahira, Yasuhiro, et al.
Publicado: (2019)

Chronic Active Epstein–Barr Virus Infection: The Elucidation of the Pathophysiology and the Development of Therapeutic Methods
por: Arai, Ayako
Publicado: (2021)

Composite Epstein-Barr Virus-associated T-lymphoblastic and Peripheral T-cell Lymphomas: A Clonal Study
por: Hosoi, Hiroki, et al.
Publicado: (2021)

Recurrent Enteritis Associated with Epstein-Barr Virus-positive CD4(+) T-cell Lymphoproliferative Disorder after Autologous Stem Cell Transplantation
por: Kawaguchi, Shinichiro, et al.
Publicado: (2020)

Cell-based laboratory evaluation of coagulation activation by antineoplastic drugs for the treatment of lymphoid tumors
por: Tsunaka, Misae, et al.
Publicado: (2016)

Dasatinib exacerbates splenomegaly of mice inoculated with Epstein-Barr virus-infected lymphoblastoid cell lines
por: Kotaki, Ryutaro, et al.
Publicado: (2020)

The expression and localization of RNase and RNase inhibitor in blood cells and vascular endothelial cells in homeostasis of the vascular system
por: Ohashi, Ayaka, et al.
Publicado: (2017)

Systemic Epstein–Barr Virus-Positive T/NK Lymphoproliferative Diseases With SH2D1A/XIAP Hypomorphic Gene Variants
por: Ishimura, Masataka, et al.
Publicado: (2019)

Advances in the Study of Chronic Active Epstein-Barr Virus Infection: Clinical Features Under the 2016 WHO Classification and Mechanisms of Development
por: Arai, Ayako
Publicado: (2019)

Anti-tumor effects of suberoylanilide hydroxamic acid on Epstein–Barr virus-associated T cell and natural killer cell lymphoma
por: Siddiquey, Mohammed NA, et al.
Publicado: (2014)

Immunization with Epstein–Barr Virus Core Fusion Machinery Envelope Proteins Elicit High Titers of Neutralizing Activities and Protect Humanized Mice from Lethal Dose EBV Challenge
por: Cui, Xinle, et al.
Publicado: (2021)

Human osteoclastogenesis in Epstein-Barr virus-induced erosive arthritis in humanized NOD/Shi-scid/IL-2Rγ(null) mice
por: Nagasawa, Yosuke, et al.
Publicado: (2021)

Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis and Guillain-Barre Syndrome in a 16-Month-Old Child
por: Matsui, Motohiro, et al.
Publicado: (2016)

Characterization of Epstein-Barr virus (EBV)-infected cells in EBV-associated hemophagocytic lymphohistiocytosis in two patients with X-linked lymphoproliferative syndrome type 1 and type 2
por: Yang, Xi, et al.
Publicado: (2012)

Efficient recruitment of c‐FLIP(L) to the death‐inducing signaling complex leads to Fas resistance in natural killer‐cell lymphoma
por: Masuda, Azuchi, et al.
Publicado: (2020)

Primary Epstein–Barr virus infection shortly after primary Cytomegalovirus infection: a case report
por: Koyama, Katsumasa, et al.
Publicado: (2021)

Plasticity of DNA Replication Initiation in Epstein-Barr Virus Episomes
por: Norio, Paolo, et al.
Publicado: (2004)

Bilateral granulomatous panuveitis in two patients with T-cell type of chronic active Epstein-Barr virus infection
por: Takahashi, Hiroyuki, et al.
Publicado: (2019)

Epstein-Barr virus induced skin rash in infectious mononucleosis
por: Akiyama, Yutaro, et al.
Publicado: (2021)

The Epstein-Barr Virus
por: Payne, L. N.
Publicado: (1980)

Development of Epstein–Barr virus-associated lymphoproliferative disorder and hemophagocytic lymphohistiocytosis during long-term lenalidomide maintenance therapy in multiple myeloma
por: Yoshida, Mina, et al.
Publicado: (2022)

Epstein - Barr virus Pneumonitis
por: McManus, Terence E, et al.
Publicado: (2009)

Epstein–Barr virus vaccines
por: Cohen, Jeffrey I
Publicado: (2015)

Epstein–barr virus vaccines
por: Cohen, Jeffrey I
Publicado: (2015)

Epstein-Barr virus and skin
por: Sangueza-Acosta, Martin, et al.
Publicado: (2018)

Epstein-Barr Virus Gastritis
por: Oki, Masayuki, et al.
Publicado: (2017)

Resurrecting Epstein–Barr Virus
por: Paganelli, Roberto
Publicado: (2022)

Epstein-Barr Virus-Associated γδ T-Cell Lymphoproliferative Disorder Associated With Hypomorphic IL2RG Mutation
por: Tanita, Kay, et al.
Publicado: (2019)

Rta is the principal activator of Epstein-Barr virus epithelial lytic transcription
por: Ali, Ahmed, et al.
Publicado: (2022)

Potential Cellular Functions of Epstein-Barr Nuclear Antigen 1 (EBNA1) of Epstein-Barr Virus
por: Smith, Danielle Westhoff, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_l47mkqfbpo5u35lsvnc1ebmvia